Cita APA

JM, S., A, M., S, F., FJ, C., C, C., C, G., . . . E, R. (2022). IBRORS-MCL study: A Spanish retrospective and observational study of relapsed/refractory mantle-cell lymphoma treated with ibrutinib in routine clinical practice.

Citación estilo Chicago

JM, Sancho, et al. IBRORS-MCL Study: A Spanish Retrospective and Observational Study of Relapsed/refractory Mantle-cell Lymphoma Treated With Ibrutinib in Routine Clinical Practice. 2022.

Cita MLA

JM, Sancho, et al. IBRORS-MCL Study: A Spanish Retrospective and Observational Study of Relapsed/refractory Mantle-cell Lymphoma Treated With Ibrutinib in Routine Clinical Practice. 2022.